DnB Asset Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $553K | Buy |
20,868
+1,373
| +7% | +$36.4K | ﹤0.01% | 644 |
|
|
2025
Q1 | $471K | Sell |
19,495
-11,171
| -36% | -$270K | ﹤0.01% | 660 |
|
|
2024
Q4 | $1.23M | Buy |
30,666
+15,209
| +98% | +$612K | 0.01% | 630 |
|
|
2024
Q3 | $979K | Buy |
15,457
+6,303
| +69% | +$399K | ﹤0.01% | 631 |
|
|
2024
Q2 | $485K | Buy |
9,154
+1,725
| +23% | +$91.4K | ﹤0.01% | 655 |
|
|
2024
Q1 | $609K | Buy |
+7,429
| New | +$609K | ﹤0.01% | 642 |
|